ELC GROUP is a fully-fledged global regulatory partner, working with major pharmaceutical stakeholders for over a decade.

From the development stage through to the implementation of clinical trials, completion of product registration, and successful marketing of the product, ELC GROUP aligns itself as a strategic partner to help pharmaceutical companies achieve their healthcare goals.




The EMA: 100 not out15/06/2018

Usually getting to a centenary in any walk of life is cause for celebration and whilst the overall tone and soundbites from the meeting were bullish, the undertones of uncertainty are still running, mainly around the issue of Brexit. »More

MHRA sets its post-Brexit strategic direction08/05/2018

The plan outlines the agency’s strategic direction over the coming 5 years and includes a section on how they plan to ensure a smooth European Union (EU) exit under any scenario. »More


The final countdown: Transition from paper/NeeS to eCTD format submission for all regulatory activities18/09/2017

eCTD is of great interest nowadays for the pharmaceutical industries, as the EMA disposed mandatory use of eCTD format for all submissions before 2019. »More

Latest Infographic

Signal Management +

Signal Management

Flow chart to illustrate the process of signal generation, detection and evaluation

View all resources